A Trial of CTS-1027 in Interferon-Naive Hepatitis C Patients.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2012
At a glance
- Drugs CTS 1027; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Conatus Pharmaceuticals
- 27 Feb 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 03 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
- 04 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History